Literature DB >> 12613129

To test or not to test: interest in genetic testing for Alzheimer's disease among middle-aged adults.

Stephen J Cutler1, Lynne G Hodgson.   

Abstract

Based on a hypothetical scenario positing 100 percent accuracy in test results, we examined interest in genetic testing for Alzheimer's disease (AD) among adult children, 40-60 years of age, who have a living parent with a diagnosis of probable AD (N = 108), and a matched comparison group of persons with no parental history of AD (N = 150). For both groups, planning for the future was the most important reason cited for being tested; lack of good treatment options and concerns about losing health insurance were the most important reasons for not being tested. Hierarchical regression was used to examine the effects of sociodemographic characteristics, subjective perceptions of memory functioning, concerns about having and developing AD, and mastery on interest in being tested. Personal concerns about developing AD and mastery emerged as significant predictors and subsample membership approached significance, although the full model explained just 18 percent of the variance. Because persons in the comparison group were more likely to report an interest in being tested, educational efforts about genetic testing should not be restricted only to family members of persons with a diagnosis of AD.

Entities:  

Mesh:

Year:  2003        PMID: 12613129     DOI: 10.1177/153331750301800106

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  8 in total

1.  Attitudes Regarding Enrollment in a Genetic Research Project: An Informed Consent Simulation Study Comparing Views of People With Depression, Diabetes, and Neither Condition.

Authors:  Jane Paik Kim; Katie Ryan; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2019-07-22       Impact factor: 1.742

2.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.

Authors:  Alon Seifan; Christine A Ganzer; Francoise Vermeylen; Stephen Parry; Jifeng Zhu; Abigail Lyons; Richard Isaacson; Sarang Kim
Journal:  J Public Health (Oxf)       Date:  2017-12-01       Impact factor: 2.341

Review 3.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

4.  Developing a framework for understanding health information behavior change from avoidance to acquisition: a grounded theory exploration.

Authors:  Haixia Sun; Jiao Li; Ying Cheng; Xuelian Pan; Liu Shen; Weina Hua
Journal:  BMC Public Health       Date:  2022-06-04       Impact factor: 4.135

Review 5.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

Review 6.  Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.

Authors:  S A S A Bemelmans; K Tromp; E M Bunnik; R J Milne; S Badger; C Brayne; M H Schermer; E Richard
Journal:  Alzheimers Res Ther       Date:  2016-11-10       Impact factor: 6.982

7.  Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial.

Authors:  Anna Rosenberg; Nicola Coley; Alexandra Soulier; Jenni Kulmala; Hilkka Soininen; Sandrine Andrieu; Miia Kivipelto; Mariagnese Barbera
Journal:  BMC Geriatr       Date:  2020-03-12       Impact factor: 3.921

8.  A 2-Study Psychometric Evaluation of the Modified Dementia Worry Scale.

Authors:  Jennifer R Roberts; Molly Maxfield
Journal:  Am J Alzheimers Dis Other Demen       Date:  2021 Jan-Dec       Impact factor: 2.035

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.